BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han NR, Moon PD, Yoo MS, Ryu KJ, Kim HM, Jeong HJ. Regulatory effects of chrysophanol, a bioactive compound of AST2017-01 in a mouse model of 2,4-dinitrofluorobenzene-induced atopic dermatitis. Int Immunopharmacol 2018;62:220-6. [PMID: 30025384 DOI: 10.1016/j.intimp.2018.06.046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohd Kasim VNK, Noble SM, Liew KY, Tan JW, Israf DA, Tham CL. Management of Atopic Dermatitis Via Oral and Topical Administration of Herbs in Murine Model: A Systematic Review. Front Pharmacol 2022;13:785782. [DOI: 10.3389/fphar.2022.785782] [Reference Citation Analysis]
2 Li X, Cheng Y, Qin Y, Gao H, Wang G, Song H, Wang Y, Cai B. Chrysophanol exerts neuroprotective effects via interfering with endoplasmic reticulum stress apoptotic pathways in cell and animal models of Alzheimer's disease. J Pharm Pharmacol 2021:rgab148. [PMID: 34791341 DOI: 10.1093/jpp/rgab148] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Moon PD, Han NR, Lee JS, Kim HM, Jeong HJ. p-coumaric acid, an active ingredient of Panax ginseng, ameliolates atopic dermatitis-like skin lesions through inhibition of thymic stromal lymphopoietin in mice. J Ginseng Res 2021;45:176-82. [PMID: 33437169 DOI: 10.1016/j.jgr.2020.06.004] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
4 Yan F, Li F, Liu J, Ye S, Zhang Y, Jia J, Li H, Chen D, Mo X. The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis. Biomed Pharmacother 2020;127:110142. [PMID: 32330795 DOI: 10.1016/j.biopha.2020.110142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
5 Su S, Wu J, Gao Y, Luo Y, Yang D, Wang P. The pharmacological properties of chrysophanol, the recent advances. Biomed Pharmacother 2020;125:110002. [PMID: 32066044 DOI: 10.1016/j.biopha.2020.110002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
6 Tang L, Li X, Wan L, Wang H, Mai Q, Deng Z, Ding H. Ameliorative effect of orally administered different linoleic acid/α-linolenic acid ratios in a mouse model of DNFB-induced atopic dermatitis. Journal of Functional Foods 2020;65:103754. [DOI: 10.1016/j.jff.2019.103754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Xie L, Tang H, Song J, Long J, Zhang L, Li X. Chrysophanol: a review of its pharmacology, toxicity and pharmacokinetics. J Pharm Pharmacol 2019;71:1475-87. [PMID: 31373015 DOI: 10.1111/jphp.13143] [Cited by in Crossref: 22] [Cited by in F6Publishing: 39] [Article Influence: 7.3] [Reference Citation Analysis]
8 Fujimoto Y, Aono K, Azuma YT. The clarified role of interleukin-19 in the inflammatory bowel disease and hypersensitivity: Insights from animal models and humans. J Vet Med Sci 2019;81:1067-73. [PMID: 31189783 DOI: 10.1292/jvms.19-0149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Han N, Kim H, Kang S, Kim MH, Yoon KW, Moon P, Kim H, Jeong H. Chrysophanol, an anthraquinone from AST2017-01, possesses the anti-proliferative effect through increasing p53 protein levels in human mast cells. Inflamm Res 2019;68:569-79. [DOI: 10.1007/s00011-019-01239-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
10 Kim HY, Jee H, Yeom JH, Jeong HJ, Kim HM. The ameliorative effect of AST2017-01 in an ovalbumin-induced allergic rhinitis animal model. Inflamm Res 2019;68:387-95. [PMID: 30874868 DOI: 10.1007/s00011-019-01226-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]